The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis.
<h4>Background</h4>The PlA1/A2 polymorphism of glycoprotein IIIa (GPIIIa) has been reported to be associated with risk of stroke in some studies, although other studies suggest no such association. This meta-analysis and systematic review was conducted to investigate the hypothesis that...
Saved in:
| Main Authors: | Christopher N Floyd, Benjamin H Ellis, Albert Ferro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0100239 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE CORRELATION OF IMMUNE AND HEMOSTATIC PARAMETERS IN PATIENTS WITH GENE POLYMORPHISM A<sup>2 </sup>RECEPTOR SUBUNITS PLATELET GLYCOPROTEIN IIB/IIIA
by: Anna Yurievna Muratova, et al.
Published: (2022-10-01) -
Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group
by: S. B. Fitilev, et al.
Published: (2022-12-01) -
A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor
by: Ömer Doğan, et al.
Published: (2021-05-01) -
EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. I. Makhiyanova, et al.
Published: (2016-01-01) -
Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial
by: S. B. Fitilev, et al.
Published: (2022-03-01)